Clinical features of gastroenteritis during a large waterborne Campylobacter outbreak in Askøy, Norway.
Campylobacter infections
Disease outbreaks
Gastroenteritis
Waterborne diseases
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
06
05
2021
accepted:
23
06
2021
pubmed:
4
7
2021
medline:
26
3
2022
entrez:
3
7
2021
Statut:
ppublish
Résumé
Outbreaks of Campylobacter infection are common, but studies exploring the clinical features of acute illness in the outbreak setting are scarce in existing literature. The main purpose of the present study was to investigate the clinical features of self-reported acute illness in gastroenteritis cases during a large waterborne Campylobacter outbreak in Askøy municipality, Norway, in 2019. A web-based self-administered questionnaire, and invitation to participate was sent by the municipality of Askøy as text message to mobile phones using the municipality's warning system to the inhabitants during the ongoing outbreak. Out of 3624 participants, 749 (20.7%) were defined as cases, of which 177 (23.6%) reported severe gastroenteritis. The most common symptoms were loose stools (90.7%), abdominal pain (89.3%) and diarrhea (88.9%), whereas 63.8% reported fever, 50.2% joint pain and 14.2% bloody stools. Tiredness, a symptom non-specific to gastroenteritis, was the overall most common symptom (91.2%). About one in four of the cases reported symptoms consistent with severe gastroenteritis. We found more joint pain and less bloody stools than reported in published studies of laboratory confirmed campylobacteriosis cases. Tiredness was common in the current study, although rarely described in previous literature of acute illness in the outbreak setting.
Identifiants
pubmed: 34215942
doi: 10.1007/s15010-021-01652-3
pii: 10.1007/s15010-021-01652-3
pmc: PMC8942940
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
343-354Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021. The Author(s).
Références
European Centre for Disease Prevention and Control (ECDC). Campylobacteriosis. In: Annual epidemiological report for 2017. Stockholm: ECDC; 2019. Available from: https://www.ecdc.europa.eu/en/publications-data/campylobacteriosis-annualepidemiological-report-2017 . Accessed 10 Apr 2021.
World Health Organization (WHO). Campylobacter. Key facts. Geneva: WHO. Available from: https://www.who.int/en/news-room/fact-sheets/detail/campylobacter . Accessed 10 April 2021.
Norwegian Veterinary Institute. The Norwegian Zoonoses Report 2019. Oslo: Norwegian Veterinary Institute; 2020. Available from: https://www.vetinst.no/rapporter-og-publikasjoner/rapporter/2020/the-norwegian-zoonoses-report-2019 . Accessed 10 April 2021.
Sandberg M, Nygard K, Meldal H, Valle PS, Kruse H, Skjerve E. Incidence trend and risk factors for campylobacter infections in humans in Norway. BMC Public Health. 2006;6:179. https://doi.org/10.1186/1471-2458-6-179 .
doi: 10.1186/1471-2458-6-179
pubmed: 16827925
pmcid: 1550237
MacDonald E, White R, Mexia R, Bruun T, Kapperud G, Lange H, et al. Risk factors for sporadic domestically acquired campylobacter infections in Norway 2010–2011: a National Prospective case-control study. PLoS ONE. 2015;10:e0139636. https://doi.org/10.1371/journal.pone.0139636 .
doi: 10.1371/journal.pone.0139636
pubmed: 26431341
pmcid: 4592224
Allos B, Calderwood SB, Bloom A. Clinical manifestations, diagnosis, and treatment of Campylobacter infection. Up-to-date. (2021). https://www.uptodate.com/contents/clinical-manifestations-diagnosis-and-treatment-of-campylobacter-infection?search=campylobacter&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 . Accessed 24 April 2021.
Blaser MJ, Berkowitz ID, LaForce FM, Cravens J, Reller LB, Wang WL. Campylobacter enteritis: clinical and epidemiologic features. Ann Intern Med. 1979;91:179–85. https://doi.org/10.7326/0003-4819-91-2-179 .
doi: 10.7326/0003-4819-91-2-179
pubmed: 380433
Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect. 2004;10:868–76. https://doi.org/10.1111/j.1469-0691.2004.00983.x .
doi: 10.1111/j.1469-0691.2004.00983.x
pubmed: 15373879
de Wit MA, Koopmans MP, Kortbeek LM, van Leeuwen NJ, Bartelds AI, van Duynhoven YT. Gastroenteritis in sentinel general practices, The Netherlands. Emerg Infect Dis. 2001;7:82–91. https://doi.org/10.3201/eid0701.700082 .
doi: 10.3201/eid0701.700082
pubmed: 11266298
pmcid: 2631671
Kapperud G, Lassen J, Ostroff SM, Aasen S. Clinical features of sporadic campylobacter infections in Norway. Scand J Infect Dis. 1992;24:741–9. https://doi.org/10.3109/00365549209062459 .
doi: 10.3109/00365549209062459
pubmed: 1287808
Kendall EJ, Tanner EI. Campylobacter enteritis in general practice. J Hyg (Lond). 1982;88:155–63. https://doi.org/10.1017/s0022172400070030 .
doi: 10.1017/s0022172400070030
McKendrick MW, Geddes AM, Gearty J. Campylobacter enteritis: a study of clinical features and rectal mucosal changes. Scand J Infect Dis. 1982;14:35–8. https://doi.org/10.3109/inf.1982.14.issue-1.07 .
doi: 10.3109/inf.1982.14.issue-1.07
pubmed: 7071525
Tribble DR, Baqar S, Scott DA, Oplinger ML, Trespalacios F, Rollins D, et al. Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans. Infect Immun. 2010;78:1750–9. https://doi.org/10.1128/IAI.01021-09 .
doi: 10.1128/IAI.01021-09
pubmed: 20086085
pmcid: 2849408
White AE, Ciampa N, Chen Y, Kirk M, Nesbitt A, Bruce BB, et al. Characteristics of campylobacter and salmonella infections and acute gastroenteritis in older adults in Australia, Canada, and the United States. Clin Infect Dis. 2019;69:1545–52. https://doi.org/10.1093/cid/ciy1142 .
doi: 10.1093/cid/ciy1142
pubmed: 30602004
Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis. 1996;22:1019–25.
doi: 10.1093/clinids/22.6.1019
Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. New Engl J Med. 2004;350:38–47. https://doi.org/10.1056/NEJMcp031534 .
doi: 10.1056/NEJMcp031534
pubmed: 14702426
Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut. 2012;61:69–77. https://doi.org/10.1136/gut.2011.238386 .
doi: 10.1136/gut.2011.238386
pubmed: 21708822
Wheeler JG, Sethi D, Cowden JM, Wall PG, Rodrigues LC, Tompkins DS, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. Br Med J. 1999;318:1046–50.
doi: 10.1136/bmj.318.7190.1046
Blaser MJ. Epidemiologic and clinical features of campylobacter jejuni infections. J Infect Dis. 1997;176:S103–5. https://doi.org/10.1086/513780 .
doi: 10.1086/513780
pubmed: 9396691
Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006;131:445–50. https://doi.org/10.1053/j.gastro.2006.05.053 .
doi: 10.1053/j.gastro.2006.05.053
pubmed: 16890598
Scallan Walter EJ, Crim SM, Bruce BB, Griffin PM. Postinfectious Irritable Bowel Syndrome After Campylobacter Infection. Am J Gastroenterol. 2019;114:1649–56. https://doi.org/10.14309/ajg.0000000000000408 .
Uotila T, Korpela M, Vuento R, Laine J, Lumio J, Kuusi M, et al. Joint symptoms after a faecal culture positive Campylobacter infection associated with a waterborne gastroenteritis outbreak: a questionnaire study. Scand J Rheumatol. 2014;43:524–6. https://doi.org/10.3109/03009742.2014.920916 .
doi: 10.3109/03009742.2014.920916
pubmed: 25205145
Wouters MM, Van Wanrooy S, Nguyen A, Dooley J, Aguilera-Lizarraga J, Van Brabant W, et al. Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut. 2016;65:1279–88. https://doi.org/10.1136/gutjnl-2015-309460 .
doi: 10.1136/gutjnl-2015-309460
pubmed: 26071133
Norwegian Directorate of Health. Norwegian guidelines for the use of antibiotics in primary care. Available from: https://www.helsedirektoratet.no/retningslinjer/antibiotikabruk-i-primaerhelsetjenesten . Accessed 27 Apr 2021.
Norwegian Directorate of Health. Norwegian guidelines for the use of antibiotics in hospitals. Available from: https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-sykehus/ . Accessed: 14 May 2021.
Ruiz-Palacios GM. The Health Burden of Campylobacter Infection and the Impact of Antimicrobial Resistance: Playing Chicken. Clin Infect Dis. 2007;44:701–3. https://doi.org/10.1086/509936 .
doi: 10.1086/509936
pubmed: 17278063
Ternhag A, Asikainen T, Giesecke J, Ekdahl K. A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis. 2007;44:696–700. https://doi.org/10.1086/509924 .
doi: 10.1086/509924
pubmed: 17278062
Hyllestad S, Iversen A, MacDonald E, Amato E, Borge BÅS, Bøe A, et al. Large waterborne Campylobacter outbreak: use of multiple approaches to investigate contamination of the drinking water supply system, Norway, June 2019. Eurosurveillance. 2020;25:1–10. https://doi.org/10.2807/1560-7917.ES.2020.25.35.2000011 .
doi: 10.2807/1560-7917.ES.2020.25.35.2000011
Mortensen N, Jonasson SA, Lavesson IV, Emberland KE, Litleskare S, Wensaas KA, et al. Characteristics of hospitalized patients during a large waterborne outbreak of Campylobacter jejuni in Norway. PLoS ONE. 2021;16: e0248464. https://doi.org/10.1371/journal.pone.0248464 .
doi: 10.1371/journal.pone.0248464
pubmed: 33755697
pmcid: 7987138
Wensaas KA, Langeland N, Hanevik K, Morch K, Eide GE, Rortveit G. Irritable bowel syndrome and chronic fatigue 3 years after acute giardiasis: historic cohort study. Gut. 2012;61:214–9. https://doi.org/10.1136/gutjnl-2011-300220 .
doi: 10.1136/gutjnl-2011-300220
pubmed: 21911849
Litleskare S, Rortveit G, Eide GE, Hanevik K, Langeland N, Wensaas KA. Prevalence of irritable bowel syndrome and chronic fatigue 10 years after giardia infection. Clin Gastroenterol Hepatol. 2018;16:1064-72.e4. https://doi.org/10.1016/j.cgh.2018.01.022 .
doi: 10.1016/j.cgh.2018.01.022
pubmed: 29378314
McNutt LA, Wu C, Xue X, Hafner JP. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003;157:940–3. https://doi.org/10.1093/aje/kwg074 .
doi: 10.1093/aje/kwg074
pubmed: 12746247
Bartholomew N, Brunton C, Mitchell P, Williamson J, Gilpin B. A waterborne outbreak of campylobacteriosis in the South Island of New Zealand due to a failure to implement a multi-barrier approach. J Water Health. 2014;12:555–63. https://doi.org/10.2166/wh.2014.155 .
doi: 10.2166/wh.2014.155
pubmed: 25252359
Jakopanec I, Borgen K, Vold L, Lund H, Forseth T, Hannula R, et al. A large waterborne outbreak of campylobacteriosis in Norway: The need to focus on distribution system safety. BMC Infect Dis. 2008;8:128. https://doi.org/10.1186/1471-2334-8-128 .
doi: 10.1186/1471-2334-8-128
pubmed: 18816387
pmcid: 2567324
Kuhn KG, Falkenhorst G, Emborg HD, Ceper T, Torpdahl M, Krogfelt KA, et al. Epidemiological and serological investigation of a waterborne Campylobacter jejuni outbreak in a Danish town. Epidemiol Infect. 2017;145:701–9. https://doi.org/10.1017/S0950268816002788 .
doi: 10.1017/S0950268816002788
pubmed: 27903324
Majowicz SE, Hall G, Scallan E, Adak GK, Gauci C, Jones TF, et al. A common, symptom-based case definition for gastroenteritis. Epidemiol Infect. 2008;136:886–94. https://doi.org/10.1017/S0950268807009375 .
doi: 10.1017/S0950268807009375
pubmed: 17686196
Kuusi M, Klemets P, Miettinen I, Laaksonen I, Sarkkinen H, Hanninen ML, et al. An outbreak of gastroenteritis from a non-chlorinated community water supply. J Epidemiol Community Health. 2004;58:273–7. https://doi.org/10.1136/jech.2003.009928 .
doi: 10.1136/jech.2003.009928
pubmed: 15026434
pmcid: 1732716
Karagiannis I, Sideroglou T, Gkolfinopoulou K, Tsouri A, Lampousaki D, Velonakis EN, et al. A waterborne Campylobacter jejuni outbreak on a Greek island. Epidemiol Infect. 2010;138:1726–34. https://doi.org/10.1017/S0950268810002116 .
doi: 10.1017/S0950268810002116
pubmed: 20836911
NORM/NORM-VET 2018. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromsø/Oslo: NORM/NORM-VET: 2019. Available from: https://www.vetinst.no/overvaking/antibiotikaresistens-norm-vet . Accessed 27 April 2021.